<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To report a case of <z:hpo ids='HP_0012123'>posterior uveitis</z:hpo> with <z:mp ids='MP_0008852'>retinal neovascularization</z:mp> in a patient with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease treated with infliximab </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A 50-year-old man with a history of recurrent relapses of <z:hpo ids='HP_0100533'>ocular inflammation</z:hpo> despite immunosuppressive therapy developed <z:mp ids='MP_0008852'>retinal neovascularization</z:mp> near the optic disk </plain></SENT>
<SENT sid="2" pm="."><plain>The patient was treated with infliximab and followed up for 12 months </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: <z:mp ids='MP_0008852'>Retinal neovascularization</z:mp> regressed 8 months after the first anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF) treatment and with six infusions of infliximab </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:hpo ids='HP_0100533'>ocular inflammation</z:hpo> resolved almost completely </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: The result suggests that anti-TNF therapy may be effective in the treatment of <z:mp ids='MP_0008852'>retinal neovascularization</z:mp> caused by <z:hpo ids='HP_0012121'>panuveitis</z:hpo> in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease </plain></SENT>
</text></document>